✦ LIBER ✦

Possible predictors of response to fluvoxamine for depression

✍ Scribed by Shigeru Morishita; Seizaburo Arita

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 49 KB
Volume: 18
Category: Article
ISSN: 0885-6222
DOI: 10.1002/hup.469

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Introduction

An investigation of the characteristics of patients being treated with antidepressants would seem to be useful in determining which patients would be most likely benefit from antidepressant medication.

Aims

The purpose of this preliminary study was to examine the possible predictors of response to fluvoxamine for depression.

Method

A retrospective cohort analysis was carried out among depression patients treated in the Department of Psychiatry, Kawasaki Medical School Hospital, Kurashiki, Japan, in 2000. Seventy two patients were identified who were receiving fluvoxamine to treat depression.

Results

A variety of clinical factors including age, gender, type of depression, frequency of episodes, family history and daily dose of fluvoxamine were examined as possible predictors of the response to fluvoxamine. A Weibull regression analysis showed age, frequency of episodes and daily dose to be the independent predictive factors of improvement in fluvoxamine treatment. The most influential factor was age (ecoef = 2.109), followed by daily dose (ecoef = 0.648) and frequency of episode (ecoef = 0.512). An age of 49 years or younger (χ^2^ = 6.767, df = 1, p = 0.0093), a first episode (χ^2^ = 9.079, df = 1, p = 0.0026) and a daily dose of 100–150 mg (χ^2^ = 5.353, df = 1, p = 0.02) were significantly better predictors of improvement.

Conclusions

Age, the frequency of episodes and the daily dose of fluvoxamine may be considered as predictors of the response to fluvoxamine treatment for depression. This result should be examined in future prospective study. Copyright © 2002 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Possible predictors of response to clona

Possible predictors of response to clonazepam augmentation therapy in patients with protracted depression

✍ Shigeru Morishita; Seizaburo Arita 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

## Abstract ## Introduction Clonazepam has been shown to be an effective supplementary treatment for depression. Thus, it would be useful to determine which patient characteristics are associated with response to clonazepam. ## Aims The purpose of this study was to examine the possible predictor

Predictors of response to sertraline in

Predictors of response to sertraline in patients with major depression

✍ Shigeru Morishita; Toshihiko Kinoshita 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

## Abstract ## Objective Investigation of the characteristics of patients being treated with antidepressants would be useful in determining which patients would most likely benefit from antidepressant. The purpose of this study was to examine the possible predictors of response to sertraline in ma

Differential effects of fluvoxamine, par

Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age

✍ Shigeru Morishita; Seizaburo Arita 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

## Abstract ## Introduction Selective serotonin reuptake inhibitors (SSRIs) and dual serotonin and noradrenaline reuptake inhibitors (SNRIs) are the most commonly prescribed classes of antidepressants, yet it is not known whether one is superior to the other. It seems that an investigation of the

Patient predictors of response to treatm

Patient predictors of response to treatment of depression in Alzheimer's disease: the DIADS study

✍ Martin Steinberg; Cynthia A. Munro; Quincy Samus; Peter V.Rabins; Jason Brandt; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

## Abstract ## Objective To investigate patient predictors of response to treatment of Major Depressive Episode (MDE) in Alzheimer's disease (AD). ## Methods Forty‐four outpatients with AD and MDE were randomized to receive either sertraline or placebo in a 12‐week placebo‐controlled, flexible‐d

Anxiety as a predictor of response to in

Anxiety as a predictor of response to interpersonal psychotherapy for recurrent major depression: An exploratory investigation

✍ Ulrike Feske; Ellen Frank; David J. Kupfer; M. Katherine Shear; Elizabeth Weaver 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

Major depression and anxiety frequently co-occur, but the implications for psychological treatments have rarely been studied. We examined predictors of acute response to interpersonal psychotherapy in 134 consecutively treated female outpatients with recurrent unipolar depression. Women who failed t

Predictors of response to clozapine ther

Predictors of response to clozapine therapy

✍ Gilbert Honigfeld; John Patin 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 324 KB

Multiple regression analysis and discriminant function analyses were applied to the question of prediction of therapeutic success or failure to clozapine therapy, using a non-biological predictor pool of 46 items. This effort was not successful, accounting for less than 25% of outcome variance under